Karah Parschauer

Executive Officer at Amlogenyx

Capital raised by Amlogenyx

$10.0M+$10.0M latest round

1 Form D filing · first filed Jul 2026 · Novato, CA

CURRENT ROLE: Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2023
30D INTEREST: —

Career

1 company on file · founded 2023

AmlogenyxBiotech · Novato, CAsince 2023

Executive Officer

Listed on Amlogenyx's Form D filings

Company filings

via EDGAR · Form D for Amlogenyx1

DateCompanyFormAmountRole on filing

Jul 1, 2026AmlogenyxForm D+$10.0M—

Form DJul 1, 2026 · Amlogenyx+$10.0Mnot a signer

Overview

Last filing Jul 1, 2026

Karah Parschauer is on file as Executive Officer at Amlogenyx in Novato, CA. Amlogenyx has 1 Form D filing on record, $10.0M raised in total.

Teammates

Amlogenyx · 1

John PinionChief Operating OfficerSigner

Products

Amlogenyx · 1

AM805Investigational AAV9 gene therapy

An investigational AAV9-mediated gene therapy designed as a one-time treatment for Alzheimer's disease, delivering protective protein/cathepsin A (PPCA) — a lysosomal carboxypeptidase — directly to the brain to degrade amyloid-beta (Abeta42).